Leinonen E
Harjamäki Hospital, Siilinjärvi, Finland.
Acta Psychiatr Scand. 1991 Apr;83(4):278-82. doi: 10.1111/j.1600-0447.1991.tb05540.x.
One hundred and sixty-nine depressive psychiatric inpatients were treated with routine therapeutic doses of mianserin. Altogether 256 serum mianserin samples were measured gas-chromatographically in 3 age groups: 17 samples in patients under 35 years, 116 samples in patients between 35 and 65 years, and 123 samples in patients over 65 years. No differences in dose-corrected (calculated as mg/kg dose basis) mean serum mianserin concentrations were found between the age classes. Neither the interindividual variation nor the number of high serum mianserin concentrations was larger among elderly subjects than in the other age groups. Concurrent neuroleptic treatment significantly increased serum mianserin levels in the oldest patient group but not in the 2 others. The results suggest that mianserin dose should not be generally reduced with advancing age.
169名患有抑郁症的精神科住院患者接受了常规治疗剂量的米安色林治疗。总共256份血清米安色林样本通过气相色谱法在3个年龄组中进行了测量:35岁以下患者有17份样本,35至65岁患者有116份样本,65岁以上患者有123份样本。在各年龄组之间,未发现以剂量校正(以mg/kg剂量为基础计算)的平均血清米安色林浓度存在差异。老年受试者的个体间差异和高血清米安色林浓度数量均不比其他年龄组大。同时进行抗精神病药物治疗显著提高了最年长患者组的血清米安色林水平,但在其他两组中未出现这种情况。结果表明,一般不应随着年龄增长而降低米安色林剂量。